Sansure Biotech Inc (688289) — Cash Flow Reinvestment Rate
Sansure Biotech Inc (688289) has a Cash Flow Reinvestment Rate of 1.06x as of September 2025, reinvesting CN¥63.08 Million (capex CN¥63.08 Million ) from operating cash flow of CN¥59.72 Million. Check 688289 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sansure Biotech Inc Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Sansure Biotech Inc across 8 annual periods. Explore cash flow to debt ratio of Sansure Biotech Inc to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Sansure Biotech Inc (2018–2025)
Year-by-year capital reinvestment analysis for Sansure Biotech Inc. For live market cap and broader valuation context, see 688289 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.12x | CN¥573.17 Million | CN¥183.96 Million | CN¥369.77 Million | ▲ +7.0% |
| 2024 | 2.91x | CN¥799.38 Million | CN¥274.45 Million | CN¥421.10 Million | ▼ -81.6% |
| 2023 | 15.86x | CN¥1.79 Billion | CN¥112.82 Million | CN¥391.35 Million | ▲ +2251.7% |
| 2022 | 0.67x | CN¥1.73 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -14.8% |
| 2021 | 0.79x | CN¥1.49 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▲ +14.6% |
| 2020 | 0.69x | CN¥1.82 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▼ -88.0% |
| 2019 | 5.75x | CN¥128.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +75.8% |
| 2018 | 3.27x | CN¥32.90 Million | CN¥10.07 Million | CN¥32.90 Million | — |